India
· Delayed Price · Currency is INR Divi's Laboratories Statistics
Total Valuation
Divi's Laboratories has a market cap or net worth of INR 1.36 trillion. The enterprise value is 1.33 trillion.
| Market Cap | 1.36T |
| Enterprise Value | 1.33T |
Important Dates
The next estimated earnings date is Monday, November 4, 2024.
| Earnings Date | Nov 4, 2024 |
| Ex-Dividend Date | Aug 2, 2024 |
Share Statistics
Divi's Laboratories has 265.47 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Shares Outstanding | 265.47M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -0.09% |
| Owned by Insiders (%) | 49.21% |
| Owned by Institutions (%) | 28.55% |
| Float | 126.82M |
Valuation Ratios
The trailing PE ratio is 81.47 and the forward PE ratio is 62.95. Divi's Laboratories's PEG ratio is 2.52.
| PE Ratio | 81.47 |
| Forward PE | 62.95 |
| PS Ratio | 16.66 |
| PB Ratio | 10.05 |
| P/FCF Ratio | n/a |
| PEG Ratio | 2.52 |
Enterprise Valuation
| EV / Earnings | 79.27 |
| EV / Sales | 16.21 |
| EV / EBITDA | 56.95 |
| EV / EBIT | 68.19 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | n/a |
| Interest Coverage | 648.67 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 9.23% |
| Revenue Per Employee | 8.40M |
| Profits Per Employee | 1.72M |
| Employee Count | 9,741 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.56% in the last 52 weeks. The beta is 0.37, so Divi's Laboratories's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +38.56% |
| 50-Day Moving Average | 4,769.22 |
| 200-Day Moving Average | 4,073.11 |
| Relative Strength Index (RSI) | 65.93 |
| Average Volume (20 Days) | 476,432 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Divi's Laboratories had revenue of INR 81.85 billion and earned 16.74 billion in profits. Earnings per share was 63.06.
| Revenue | 81.85B |
| Gross Profit | 46.68B |
| Operating Income | 19.46B |
| Pretax Income | 22.75B |
| Net Income | 16.74B |
| EBITDA | 23.29B |
| EBIT | 19.46B |
| Earnings Per Share (EPS) | 63.06 |
Balance Sheet
The company has 36.98 billion in cash and 30.00 million in debt, giving a net cash position of 36.95 billion or 139.19 per share.
| Cash & Cash Equivalents | 36.98B |
| Total Debt | 30.00M |
| Net Cash | 36.95B |
| Net Cash Per Share | 139.19 |
| Equity (Book Value) | 135.71B |
| Book Value Per Share | 511.21 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 57.03%, with operating and profit margins of 23.78% and 20.45%.
| Gross Margin | 57.03% |
| Operating Margin | 23.78% |
| Pretax Margin | 27.79% |
| Profit Margin | 20.45% |
| EBITDA Margin | 28.45% |
| EBIT Margin | 23.78% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 30.00, which amounts to a dividend yield of 0.58%.
| Dividend Per Share | 30.00 |
| Dividend Yield | 0.58% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.58% |
| Earnings Yield | 1.23% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on September 23, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Sep 23, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |